Oncology-focused biotech firm BeOne Medicines pops into buy range, boosted by strong demand and stellar earnings growth. The post BeOne Stock Breaks Out With Visions Of 177% Earnings Growth. This Telltale Clue Bodes Well. appeared first on Investor's Business Daily .
BeOne Medicines Ltd. American Depositary Shares (ONC) News
Latest headlines that mention ONC, newest first · each headline opens the original publisher
- Last price
- $382.27
- Day change
- -1.08%
- Next earnings
- 2026-11-05
ONC headlines
latest coverageBiotech leader BeOne stock is poised to hit multiple buy points. Its blockbuster drug generated $1.2 billion in sales in the second quarter. The post Biotech Leader BeOne Medicines Poised To Hit Early Buy Points appeared first on Investor's Business Daily .
BRUKINSA revenue surged 31% while management raised full-year guidance by $300 million.
ONC news alerts
Get an alert by email or push when a new headline mentions ONC.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.